Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma

Lymphocyte Activation Gene-3 Maintains Mitochondrial and Metabolic Quiescence in Naive CD4+ T Cells

(2019) Dana M. Previte et al.   Cell Reports

Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy

(2018) Xianda Zhao et al.   PHARMACOLOGY & THERAPEUTICS

Genomic Characterization of TP53–Wild-Type Esophageal Carcinoma

(2018) Alexander Quaas et al.   Translational Oncology

Function and regulation of LAG3 on CD4 + CD25 - T cells in non-small cell lung cancer

(2017) Qin-Yun Ma et al.   EXPERIMENTAL CELL RESEARCH

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

(2017) Mika Shapiro et al.   HAEMATOLOGICA

LAG3 (CD223) as a cancer immunotherapy target

(2017) Lawrence P. Andrews et al.   IMMUNOLOGICAL REVIEWS

Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?

(2017) Paolo A. Ascierto et al.   Journal of Translational Medicine

The immune contexture in cancer prognosis and treatment

(2017) Wolf H. Fridman et al.   Nature Reviews Clinical Oncology

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

(2017) Mika Shapiro et al.   HAEMATOLOGICA

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas

(2017) François Bertucci et al.   OncoImmunology

Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma

(2016) Fergus Noble et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Lymphocyte-activation gene-3, an important immune checkpoint in cancer

(2016) Yayi He et al.   CANCER SCIENCE

Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas

(2016) Doris Helbig et al.   Oncotarget

LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model

(2015) Ruea-Yea Huang et al.   Oncotarget

PDL1 expression is an independent prognostic factor in localized GIST

(2015) François Bertucci et al.   OncoImmunology

The effect of immune microenvironment on the progression and prognosis of colorectal cancer

(2014) Jinxiang Chen et al.   MEDICAL ONCOLOGY

Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8+ T cell in HCC patients

(2012) Fu-Jun Li et al.   IMMUNOLOGY LETTERS

MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis

(2011) P. Hemon et al.   JOURNAL OF IMMUNOLOGY

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

(2011) Matthew Bott et al.   NATURE GENETICS

Response Evaluation by Endoscopy, Rebiopsy, and Endoscopic Ultrasound Does Not Accurately Predict Histopathologic Regression After Neoadjuvant Chemoradiation for Esophageal Cancer

(2008) Paul M. Schneider et al.   ANNALS OF SURGERY